Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective

J Clin Oncol. 2011 Jun 1;29(16):e489; author reply e490-1. doi: 10.1200/JCO.2011.34.9431. Epub 2011 Apr 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antineoplastic Agents / adverse effects*
  • Calcium Gluconate / administration & dosage*
  • Clinical Trials as Topic / methods*
  • Colonic Neoplasms / drug therapy
  • Early Termination of Clinical Trials
  • Humans
  • Infusions, Intravenous
  • Magnesium Sulfate / administration & dosage*
  • Neurotoxicity Syndromes / prevention & control
  • Organoplatinum Compounds / adverse effects*
  • Oxaliplatin
  • Peripheral Nervous System Diseases / prevention & control*
  • Research Design
  • Sensory Receptor Cells / drug effects

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin
  • Magnesium Sulfate
  • Calcium Gluconate